Robert L. Noble Prize: Difference between revisions
Appearance
Content deleted Content added
→Recipients: add 2010, remove 1993 (not listed on the website) |
Add columns-list |
||
Line 4: | Line 4: | ||
==Recipients== |
==Recipients== |
||
{{columns-list|2| |
|||
* 2010 - [[Mitsu Ikura]] |
* 2010 - [[Mitsu Ikura]] |
||
* 2009 - [[Brian Wilson (disambiguation)|Brian Wilson]] |
* 2009 - [[Brian Wilson (disambiguation)|Brian Wilson]] |
||
Line 21: | Line 22: | ||
* 1995 - [[Anthony Pawson|Anthony J. Pawson]] |
* 1995 - [[Anthony Pawson|Anthony J. Pawson]] |
||
* 1994 - [[Victor Ling]] |
* 1994 - [[Victor Ling]] |
||
}} |
|||
==External links== |
==External links== |
Revision as of 14:52, 5 August 2011
The Robert L. Noble Prize (not to be confused with the Nobel Prize) is awarded each year by the National Cancer Institute of Canada to researchers whose contributions have led to a significant advance in cancer research. The prize consists of 2,000 Canadian dollars for the researcher receiving the prize, and an additional 20,000 Canadian dollars to further his/her cancer research.
It honours Dr. Robert L. Noble, a Canadian researcher who in the 1950s helped with the discovery of vincristine and vinblastine, widely-used anti-cancer drugs.
Recipients
2